Peter Krippl Selected Research

Peter Krippl Research Topics

Disease

21	Neoplasms (Cancer) 09/2018 - 09/2003
20	Breast Neoplasms (Breast Cancer) 03/2015 - 06/2003
7	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2004
3	Colorectal Neoplasms (Colorectal Cancer) 04/2011 - 05/2008
3	Prostatic Neoplasms (Prostate Cancer) 07/2008 - 02/2007
2	Primary Myelofibrosis (Myelosclerosis) 09/2018 - 05/2017
2	Carcinogenesis 02/2006 - 05/2004
1	Cardiac Arrhythmias (Arrythmia) 09/2017
1	Atrial Fibrillation 09/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2012
1	Hemorrhage 02/2012
1	Hypoxia (Hypoxemia) 09/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2010
1	Peripheral Arterial Disease 02/2010
1	Inflammation (Inflammations) 02/2010
1	Mesothelioma 11/2006
1	Poliomyelitis (Polio) 11/2006
1	Lymphatic Metastasis 02/2006
1	Vomiting 01/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2006
1	Hearing Loss (Hearing Impairment) 01/2006
1	Nausea 01/2006
1	Acute Kidney Injury (Acute Renal Failure) 01/2006

Drug/Important Bio-Agent (IBA)

7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 09/2003
6	Progesterone Receptors (Progesterone Receptor)IBA 02/2010 - 09/2003
4	Interleukin-10 (Interleukin 10)IBA 12/2010 - 03/2005
4	Estrogens (Estrogen)FDA Link 03/2005 - 09/2003
3	EnzymesIBA 05/2017 - 09/2003
3	IntegrinsIBA 04/2011 - 05/2006
2	ruxolitinibIBA 09/2018 - 05/2017
2	Estrogen ReceptorsIBA 11/2010 - 02/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2010 - 09/2003
2	Cyclin D1IBA 07/2005 - 12/2003
1	Phosphotransferases (Kinase)IBA 09/2018
1	Azacitidine (5 Azacytidine)FDA Link 11/2014
1	Inosine Triphosphate (ITP)IBA 02/2012
1	Epirubicin (Ellence)FDA LinkGeneric 06/2011
1	Tamoxifen FDA LinkGeneric 11/2010
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010
1	Monoclonal AntibodiesIBA 09/2010
1	Oxygen (Dioxygen)IBA 09/2010
1	ProstaglandinsIBA 02/2010
1	Factor XII (Hageman Factor)IBA 02/2010
1	Capecitabine (Xeloda)FDA Link 01/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010
1	Lapatinib (GW572016)FDA Link 01/2010
1	LigandsIBA 02/2008
1	Cysteine (L-Cysteine)FDA Link 02/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2008
1	DNA (Deoxyribonucleic Acid)IBA 11/2006
1	AsbestosIBA 11/2006
1	VaccinesIBA 11/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2006
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	CytokinesIBA 03/2005
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2004
1	Arginine (L-Arginine)FDA Link 09/2004
1	Histidine (L-Histidine)FDA Link 09/2004
1	Amino Acids FDA Link 09/2004
1	SulfotransferasesIBA 09/2004
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 05/2004
1	GTP-Binding Proteins (G-Protein)IBA 03/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2003
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 09/2003
1	HomocysteineIBA 09/2003
1	PlatinumIBA 06/2003

Therapy/Procedure

3	Therapeutics 09/2018 - 01/2010
3	Drug Therapy (Chemotherapy) 06/2011 - 06/2003
1	Art Therapy 09/2017
1	Stem Cell Transplantation 05/2017
1	Radiotherapy 02/2008
1	Lasers (Laser) 07/2006
1	Adjuvant Chemotherapy 06/2003